Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1970 Jun;49(6):1266–1279. doi: 10.1172/JCI106339

The effect of diphenylhydantoin on thyroxine metabolism in man

P R Larsen 1,2,3,4, A J Atkinson Jr 1,2,3,4, H N Wellman 1,2,3,4, R E Goldsmith 1,2,3,4
PMCID: PMC322591  PMID: 4987171

Abstract

The effect of 5,5′-diphenylhydantoin on thyroxine metabolism was examined in five normal volunteers. Intravenous injection of radiothyroxine was followed by a 10-12 day control and subsequent 9-14 day treatment periods. During oral administration of diphenylhydantoin, plasma thyroxine concentration decreased to about 80% of its pretreatment level and the plasma radiothyroxine disappearance rate increased a maximum of 20% over control estimates. These changes were a result of increases in both urinary and fecal excretion of radioisotope.

A minimum plasma thyroxine was apparent after 10-12 days of diphenylhydantoin administration. In two of the subjects, treatment was sufficiently prolonged to achieve this new steady state. In these subjects, the decrease in total body thyroxine was balanced by the increase in the fractional turnover rate. As a result, absolute thyroxine degradation during diphenylhydantoin administration was unchanged from the pretreatment values.

Plasma ultrafiltration was used to estimate the free thyroxine fraction at regular intervals during the control and treatment periods. During diphenylhydantoin treatment, there was little or no change in this fraction and therefore, absolute free thyroxine decreased. Thyroxine-binding globulin and thyroxine-binding prealbumin capacities remained constant.

These results indicate that thyroxine degradation can proceed at a normal rate in subjects receiving diphenylhydantoin despite decreases in plasma free thyroxine concentration. If free thyroxine is the only portion of the hormone available for cellular utilization, then free thyroxine clearance must be increased in these subjects. This increase in clearance could represent either a direct stimulation of peripheral thyroxine metabolism by diphenylhydantoin, or it could reflect the response of intrinsic regulatory systems to a diphenylhydantoin-mediated displacement of thyroxine from thyroxine-binding globulin. Whatever the mechanism for this effect, a decreased free thyroxine value in patients receiving diphenylhydantoin may not imply hypothyroidism.

Full text

PDF
1266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERMAN M., WEISS M. F., SHAHN E. Some formal approaches to the analysis of kinetic data in terms of linear compartmental systems. Biophys J. 1962 May;2:289–316. doi: 10.1016/s0006-3495(62)86856-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassidy C. E., Benotti J., Peno S. Clinical evaluation of the determination of thyroxine iodine. J Clin Endocrinol Metab. 1968 Mar;28(3):420–421. doi: 10.1210/jcem-28-3-420. [DOI] [PubMed] [Google Scholar]
  3. Cavalieri R. R., Searle G. L. The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin. J Clin Invest. 1966 Jun;45(6):939–949. doi: 10.1172/JCI105409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chin W., Schussler G. C. Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin. J Clin Endocrinol Metab. 1968 Feb;28(2):181–186. doi: 10.1210/jcem-28-2-181. [DOI] [PubMed] [Google Scholar]
  5. ELZINGA K. E., CARR E. A., Jr, BEIERWALTES W. H. Adaptation of the standard Durrum-type cell for reverse-flow paper electrophoresis. Am J Clin Pathol. 1961 Aug;36:125–131. doi: 10.1093/ajcp/36.2.125. [DOI] [PubMed] [Google Scholar]
  6. INGBAR S. H., FREINKEL N. Regulation of the peripheral metabolism of the thyroid hormones. Recent Prog Horm Res. 1960;16:353–403. [PubMed] [Google Scholar]
  7. INGBAR S. H., FREINKEL N. Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. J Clin Invest. 1955 Jun;34(6):808–819. doi: 10.1172/JCI103136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ingbar S. H. CLINICAL AND PHYSIOLOGICAL OBSERVATIONS IN A PATIENT WITH AN IDIOPATHIC DECREASE IN THE THYROXINE-BINDING GLOBULIN OF PLASMA. J Clin Invest. 1961 Nov;40(11):2053–2063. doi: 10.1172/JCI104431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nicoloff J. T., Dowling J. T. Estimation of thyroxine distribution in man. J Clin Invest. 1968 Jan;47(1):26–37. doi: 10.1172/JCI105712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. OPPENHEIMER J. H., FISHER L. V., NELSON K. M., JAILER J. W. Depression of the serum protein-bound iodine level by diphenylhydantion. J Clin Endocrinol Metab. 1961 Mar;21:252–262. doi: 10.1210/jcem-21-3-252. [DOI] [PubMed] [Google Scholar]
  11. OPPENHEIMER J. H., TAVERNETTI R. R. Displacement of thyroxine from human thyroxine-binding globulin by analogues of hydantoin. Steric aspects of the thyroxinebinding site. J Clin Invest. 1962 Dec;41:2213–2220. doi: 10.1172/JCI104680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Oppenheimer J. H., Bernstein G., Surks M. I. Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital. J Clin Invest. 1968 Jun;47(6):1399–1406. doi: 10.1172/JCI105831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Oppenheimer J. H., Martinez M., Bernstein G. Determination of the maximal binding capacity and protein concentration of thyroxine-binding prealbumin in human serum. J Lab Clin Med. 1966 Mar;67(3):500–509. [PubMed] [Google Scholar]
  14. Schussler G. C., Plager J. E. Effect of preliminary purification of 131-I-thyroxine on the determination of free thyroxine in serum. J Clin Endocrinol Metab. 1967 Feb;27(2):242–250. doi: 10.1210/jcem-27-2-242. [DOI] [PubMed] [Google Scholar]
  15. Sterling K., Brenner M. A. Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest. 1966 Jan;45(1):153–163. doi: 10.1172/JCI105320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. WOLFF J., STANDAERT M. E., RALL J. E. Thyroxine displacement from serum proteins and depression of serum protein-bound iodine by certain drugs. J Clin Invest. 1961 Aug;40:1373–1379. doi: 10.1172/JCI104368. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES